In this episode, we spotlight Plenary Lecture 06 from the AD/PD™ 2025 International Conference — “Pivotal Points in Prevention Trials and the New Era of Precision Medicine for Alzheimer’s Disease and Related Disorders.”
The session was chaired by Prof. Gabriel Gold (Switzerland), with the lecture delivered by Prof. Miia Kivipelto (Sweden), an internationally recognized leader in dementia prevention research.
Key highlights include:
• Results from the landmark FINGER study and the global expansion through Worldwide FINGERS, now active in 70 countries• Evidence showing that delaying dementia onset by five years could cut cases by 50% worldwide
• Insights into modifiable risk factors — lifestyle, vascular, metabolic, and environmental — and the importance of early intervention
• Emerging studies, such as HAHA, which explores the role of hearing aids in preventing cognitive decline
• Long-term cognitive, cardiovascular, and cost-effectiveness benefits of multi-domain prevention strategies
• The potential of personalized and precision prevention, combining lifestyle interventions with pharmacological treatments like metformin
• Ongoing work to harmonize global research, validate tools, and ensure effective implementation in clinical practice
This episode is essential listening for clinicians, researchers, policymakers, and anyone interested in the future of Alzheimer’s prevention, precision medicine, and brain health strategies at both individual and population levels.
This podcast was created using AI to provide a quick and insightful summary of an AD/PD™ 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
The AD/PD™ 2025 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders, took place on April 1-5, 2025, in Vienna Austria.
https://adpd.kenes.com/